NUVATION BIO INC's ticker is NUVB and the CUSIP is 67080N101. A total of 125 filers reported holding NUVATION BIO INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 28,212,376 | $280,431,000 | 31.46% |
| Aisling Capital Management LP | 2,541,009 | $25,258,000 | 5.04% |
| Ally Bridge Group (NY) LLC | 1,660,947 | $16,510,000 | 4.85% |
| EcoR1 Capital, LLC | 13,711,517 | $136,292,000 | 4.74% |
| Avidity Partners Management LP | 7,263,488 | $72,199,000 | 1.60% |
| Boxer Capital, LLC | 4,341,009 | $43,150,000 | 1.51% |
| Abrams Capital Management | 3,811,513 | $37,886,000 | 0.83% |
| Redmile Group, LLC | 4,541,009 | $45,138,000 | 0.79% |
| Baupost Group | 8,623,021 | $85,368,000 | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,577,233 | $35,558,000 | 0.69% |